Lucid Diagnostics Inc.
NASDAQ:LUCD
1.04 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 2.428 | 0.377 | 0.5 | 0 | 0 | 0 |
| Cost of Revenue
| 8.478 | 3.614 | 0.585 | 0 | 0 | 0 |
| Gross Profit
| -6.05 | -3.237 | -0.085 | 0 | 0 | 0 |
| Gross Profit Ratio
| -2.492 | -8.586 | -0.17 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 7.252 | 11.466 | 9.296 | 5.443 | 3.462 | 0.716 |
| General & Administrative Expenses
| 19.254 | 23.685 | 12.778 | 2.837 | 0.959 | 0.615 |
| Selling & Marketing Expenses
| 16.404 | 16.134 | 5.26 | 1.305 | 0 | -0.205 |
| SG&A
| 35.18 | 39.819 | 18.038 | 2.837 | 0.959 | 0.41 |
| Other Expenses
| -4.166 | 1.649 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 42.432 | 52.934 | 27.334 | 8.28 | 4.421 | 1.126 |
| Operating Income
| -48.482 | -56.171 | -27.419 | -8.28 | -4.421 | -1.126 |
| Operating Income Ratio
| -19.968 | -148.995 | -54.838 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -4.184 | 0 | -0.659 | 0 | -0 | -0 |
| Income Before Tax
| -52.666 | -56.171 | -28.078 | -8.28 | -4.421 | -1.126 |
| Income Before Tax Ratio
| -21.691 | -148.995 | -56.156 | 0 | 0 | 0 |
| Income Tax Expense
| 2.331 | 1.708 | 0.659 | -8.28 | -4.421 | -1.689 |
| Net Income
| -52.666 | -56.171 | -28.737 | -8.28 | -4.421 | -1.126 |
| Net Income Ratio
| -21.691 | -148.995 | -57.474 | 0 | 0 | 0 |
| EPS
| -1.26 | -1.55 | -0.82 | -0.22 | -0.12 | -0.03 |
| EPS Diluted
| -1.26 | -1.55 | -0.82 | -0.22 | -0.12 | -0.03 |
| EBITDA
| -45.983 | -54.235 | -27.415 | -8.28 | -4.421 | -1.126 |
| EBITDA Ratio
| -18.939 | -143.859 | -54.83 | 0 | 0 | 0 |